^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    vantictumab (OMP-18R5)

    i
    Other names: OMP-18R5
    Company:
    Mereo Biopharma, Novartis
    Drug class:
    Wnt signalling pathway inhibitor
    Related drugs: